Shares of Aimei Health Technology Co., Ltd. (NASDAQ:AFJK - Get Free Report) were down 0.1% on Tuesday . The company traded as low as $11.32 and last traded at $11.32. Approximately 113 shares traded hands during mid-day trading, a decline of 97% from the average daily volume of 4,438 shares. The stock had previously closed at $11.33.
Aimei Health Technology Stock Down 0.1%
The stock's 50-day moving average price is $11.25 and its 200 day moving average price is $11.14. The firm has a market capitalization of $69.28 million, a price-to-earnings ratio of 49.22 and a beta of -0.02.
Aimei Health Technology (NASDAQ:AFJK - Get Free Report) last released its quarterly earnings data on Wednesday, August 13th. The company reported $0.07 earnings per share for the quarter.
Hedge Funds Weigh In On Aimei Health Technology
Several hedge funds have recently bought and sold shares of the company. Polar Asset Management Partners Inc. purchased a new position in Aimei Health Technology in the 1st quarter valued at approximately $110,000. Wellspring Financial Advisors LLC acquired a new stake in shares of Aimei Health Technology in the second quarter valued at $133,000. Clear Street LLC grew its stake in Aimei Health Technology by 63.8% during the 2nd quarter. Clear Street LLC now owns 39,525 shares of the company's stock worth $441,000 after purchasing an additional 15,399 shares in the last quarter. Quarry LP increased its holdings in Aimei Health Technology by 4.7% during the 1st quarter. Quarry LP now owns 157,081 shares of the company's stock worth $1,729,000 after purchasing an additional 7,081 shares during the period. Finally, Crossingbridge Advisors LLC acquired a new stake in Aimei Health Technology in the 2nd quarter valued at about $2,147,000. Institutional investors and hedge funds own 45.58% of the company's stock.
About Aimei Health Technology
(
Get Free Report)
Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aimei Health Technology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aimei Health Technology wasn't on the list.
While Aimei Health Technology currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.